Preferential depletion of gut CD4-expressing iNKT cells contributes to systemic immune activation in HIV-1 infection

Mucosal Immunology

Volumn 6, Issue 3, 2013, Pages 591-600

  Ibarrondo, F J ^a   Wilson, S B ^b   Hultin, L E ^a   Shih, R ^a   Hausner, M A ^a   Hultin, P M ^a   Anton, P A ^a   Jamieson, B D ^a   Yang, O O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ARTICLE; BLOOD; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOSTIMULATION; INTESTINE; INVARIANT RECEPTOR NATURAL KILLER T CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; NATURAL KILLER T CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 84876352381     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.101     Document Type: Article

References (50)

1. Wilson, S.B. & Delovitch, T.L. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat. Rev. Immunol. 3, 211-222 (2003).
2. Godfrey, D.I., Stankovic, S. & Baxter, A.G. Raising the NKTcell family. Nat. Immunol. 11, 197-206 (2010).
3. Godfrey, D.I. & Rossjohn, J. New ways to turn on NKT cells. J. Exp. Med. 208, 1121-1125 (2011).
4. Joyce, S., Girardi, E. & Zajonc, D.M. NKT cell ligand recognition logic: molecular basis for a synaptic duet and transmission of inflammatory effectors. J. Immunol. 187, 1081-1089 (2011).
5. Yang, O.O. et al. CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of V alpha 24J alpha Q T cells: a feedback mechanism for immune regulation. J. Immunol. 165, 3756-3762 (2000).
6. Brigl, M. et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208, 1163-1177 (2011).
7. Snyder-Cappione, J.E.et al. A comprehensiveex vivo functional analysis of human NKTcells reveals production of MIP1-alpha and MIP1-beta, a lack of IL-17, and a Th1-bias in males. PLoS One 5 e15412 (2010).
8. Gumperz, J.E., Miyake, S., Yamamura, T. & Brenner, M.B. Functionally distinct subsets of CD1d-restricted natural killer Tcells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
9. Wilson, S.B. et al. Extreme Th1 bias of invariant Valpha 24J alpha Q Tcells in type 1 diabetes. Nature 391, 177-181 (1998).
10. Brigl, M. & Brenner, M.B. CD1: Antigen presentation and T cell function. Annu. Rev. Immunol. 22, 817-890 (2004).
11. Berzins, S.P., Smyth, M.J. & Baxter, A.G. Presumed guilty: natural killer T cell defects and human disease. Nat. Rev. Immunol. 11, 131-142 (2011).
12. Lee, P.T., Benlagha, K., Teyton, L. & Bendelac, A. Distinct functional lineages of human V alpha-24 natural killer T cells. J. Exp. Med. 195, 637-641 (2002).
13. Fleuridor, R. et al. CD1d-restricted natural killer Tcells are potent targets for human immunodeficiency virus infection. Immunology 108, 3-9 (2003).
14. Thomas, S.Y. et al. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171, 2571-2580 (2003).
15. Motsinger, A. et al. CD1d-restricted human natural killer Tcells are highly susceptible to human immunodeficiency virus 1 infection. J. Exp. Med. 195, 869-879 (2002).
16. Crowe, N.Y., Godfrey, D.I. & Baxter, A.G. Natural killer T cells are targets for human immunodeficiency virus infection. Immunology 108, 1-2 (2003).
17. Li, D. & Xu, X.N. NKTcells in HIV-1 infection. Cell Res. 18, 817-822 (2008).
18. van der Vliet, H.J. et al. Selective decreaseincirculatingValpha24+Vbeta 11 + NKT cells during HIV type 1 infection. J. Immunol. 168, 1490-1495 (2002).
19. Sandberg, J.K. et al. Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 76, 7528-7534 (2002).
20. Yang, O.O. et al. Delayed reconstitution of CD4+ iNKTcells after effective HIV type 1 therapy. AIDS Res. Hum. Retroviruses 23, 913-922 (2007).
21. Mowat, A.M. & Viney, J.L. The anatomical basis of intestinal immunity. Immunol. Rev. 156, 145-166 (1997).
22. Anton, P.A. et al. Enhanced levels of functional HIV-1 co-receptors on human mucosal Tcells demonstrated using intestinal biopsy tissue. AIDS 14, 1761-1765 (2000).
23. Shacklett, B.L. & Anton, P.A. HIV infection and gut mucosal immune function: updates on pathogenesis with implications for management and intervention. Curr. Infect. Dis. Rep. 12, 19-27 (2010).
24. Schneider, T. et al. Loss of Cd4 T-lymphocytes in patients infected with human-immunodeficiency-virus type-1 is more pronounced in the duodenal mucosa than in the peripheral-blood. Gut 37, 524-529 (1995).
25. Brenchley, J.M. & Douek, D.C. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 1, 23-30 (2008).
26. Marchetti, G. et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 25, 1385-1394 (2011).
27. Merlini, E. et al. Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy. PLoS One. 6, e18580 (2011).
28. Unutmaz, D. NKT cells and HIV infection. Microbes Infect. 5, 1041-1047 (2003).
29. Mothe, B. et al. CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV control. PLoS One. 7, e29717 (2012).
30. Grossman, Z., Meier-Schellersheim, M., Paul, W.E. & Picker, L.J. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 12, 289-295 (2006).
31. Fevrier, M., Dorgham, K. & Rebollo, A. CD4 + T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis. Viruses 3, 586-612 (2011).
32. Guadalupe, M. et al. Severe CD4(+)T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77, 11708-11717 (2003).
33. Van Dieren, J.M. et al. Roles of CD1d-restricted NKT cells in the intestine. Inflamm. Bowel Dis. 13, 1146-1152 (2007).
34. Kaser, A., Zeissig, S. & Blumberg, R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573-621 (2010).
35. Wei, B. et al. Commensal microbiota and CD8+ T cells shape the formation of invariant NKT cells. J. Immunol. 184, 1218-1226 (2010).
36. Middendorp, S. & Nieuwenhuis, E.E. NKT cells in mucosal immunity. Mucosal Immunol. 2, 393-402 (2009).
37. Nieuwenhuis, E.E. et al. Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J. Clin. Invest. 119, 1241-1250 (2009).
38. Fuss, I.J. et al. Nonclassical CD1d-restricted NK Tcells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113, 1490-1497 (2004).
39. Rout, N. et al. Paucity of CD4 + natural killer T (NKT) lymphocytes in Sooty Mangabeys is associated with lack of NKTcell depletion after SIV infection. PLoS One. 5, e9787 (2010).
40. Salgado, M. et al. Long-term non-progressors display a greater number of Th17 cells than HIV-infected typical progressors. Clin. Immunol. 139, 110-114 (2011).
41. Milpied, P. et al. IL-17-producing invariant NKTcellsin lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. Blood 118, 2993-3002 (2011).
42. Moreira-Teixeira, L. et al. Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKTcells. J. Immunol. 186, 5758-5765 (2011).
43. Prendergast, A. et al. HIV-1 infection is characterized by profound depletion of CD161 + Th17 cells and gradual decline in regulatory T cells. AIDS 24, 491-502 (2010).
44. Elhed, A. & Unutmaz, D. Th17 cells and HIV infection. Curr. Opin. HIV AIDS 5, 146-150 (2010).
45. El, H.A. et al. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J. Infect. Dis. 201, 843-854 (2010).
46. Ndhlovu, L.C. et al. SuppressionofHIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection. AIDS 22, 990-992 (2008).
47. Haynes, B.F. Gut microbes out of control in HIV infection. Nat. Med. 12, 1351-1352 (2006).
48. Shacklett, B.L. et al. Optimization of methods to assess human mucosal T-cell responses to HIV infection. J. Immunol. Methods 279, 17-31 (2003).
49. Ibarrondo, F.J. et al. Parallel human immunodeficiency virus type 1-specific CD8 + T-lymphocyte responses in blood and mucosa during chronic infection. J. Virol. 79, 4289-4297 (2005).
50. Bricard, G. et al. Enrichment of human CD4 + V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors. J. Immunol. 182, 5140-5151 (2009).